
In a precedential ruling, the U.S. Court of Appeals for the Federal Circuit in Jazz Pharma. v. Avadel CNS Pharma., 2025 WL 1298920, — F.4th — (Fed. Cir. May 6, 2025), addressed the scope of the 35 U.S.C. § 271(e)(1)
The Fedtrade® podcast recently interviewed Doug Baker, Vice President of Industry Relations at FMI – The Food Industry Association, as part of our SelectUSA Investment Summit Spotlight series. As the food industry association, FMI works with and on behalf of…
The Fedtrade® podcast recently interviewed Lisa Pettigrew, CEO and Founder of CRO Syndicate, as part of our SelectUSA Investment Summit Spotlight series. CRO Syndicate provides seasoned interim executives to exponentially grow your company’s revenue through strategic, collaborative, and pragmatic real-world…
The Fedtrade® podcast recently interviewed Charuni Patibanda-Sanchez, Secretary of State of Delaware, as part of our SelectUSA Investment Summit Spotlight series. As Secretary of State, Charuni leads the most diverse department with responsibilities in virtually every aspect of Delaware state…
The Fedtrade® podcast recently interviewed Tracey Hyatt Bosman, Managing Director of Biggins Lacy Shapiro & Company (BLS & Co.), as part of our SelectUSA Investment Summit Spotlight series. BLS & Co. is one of the largest specialty site selection and…
A. Introduction: Harnessing Cellular Machinery for Precision Medicine
Targeted protein degradation (TPD) is transforming drug discovery by leveraging the cell’s natural protein disposal systems to eliminate disease-causing proteins. Innovators are making rapid and successful advancements in the field of targeted protein…
The Fedtrade® podcast recently interviewed Anders Victor, Director of Business Development for the Economic Development Partnership of North Carolina (EDPNC), as part of our SelectUSA Investment Summit Spotlight series. EDPNC improves the economic well-being and quality of life for all…
The Patent Trial and Appeal Board (PTAB) recently designated its decision in Cambridge v. Sfara (IPR2024-00952) as an informative decision.[1] This designation addresses an important issue in inter partes review (IPR) proceedings: inconsistent claim construction arguments between district court…